Alain Vuong
Overview
Explore the profile of Alain Vuong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wechsler R, Leroy R, Van Cott A, Hammer A, Vuong A, Huffman R, et al.
Epilepsy Res
. 2014 Jun;
108(6):1128-36.
PMID: 24888248
Purpose: To determine the tolerability and efficacy of lamotrigine extended-release (LTG XR) as adjunctive therapy with optional conversion to monotherapy in patients ages≥65 years with epilepsy. Methods: This open-label study...
2.
Biton V, Shneker B, Naritoku D, Hammer A, Vuong A, Caldwell P, et al.
Clin Drug Investig
. 2013 Mar;
33(5):359-64.
PMID: 23475541
Background: In three randomized double-blind clinical trials, lamotrigine extended-release (lamotrigine XR) was demonstrated to be effective in the adjunctive treatment of intractable partial seizures or primary generalized tonic-clonic seizures and...
3.
French J, Hammer A, Vuong A, Messenheimer J
Epilepsy Res
. 2012 Apr;
101(1-2):141-7.
PMID: 22497754
Early withdrawal of patients from a clinical trial can compromise the robustness of the data by introducing bias into the analysis. This is most commonly addressed by using the "intent...
4.
Bullman J, Nicholls A, Van Landingham K, Fleck R, Vuong A, Miller J, et al.
Epilepsia
. 2011 Jun;
52(7):1351-8.
PMID: 21635243
Purpose: Statins and antiepileptic drugs (AEDs) are frequently coprescribed to individuals with hypercholesterolemia and new-onset seizures. Statins are metabolized by the cytochrome P450 (CYP) enzyme system. Interactions between statins and...
5.
Biton V, Di Memmo J, Shukla R, Lee Y, Poverennova I, Demchenko V, et al.
Epilepsy Behav
. 2010 Oct;
19(3):352-8.
PMID: 20937567
Efficacy and tolerability of once-daily adjunctive lamotrigine extended-release (XR) for primary generalized tonic-clonic (PGTC) seizures in epilepsy were evaluated. Patients (n = 153) ≥ 13 years old diagnosed with epilepsy...
6.
Labiner D, Ettinger A, Fakhoury T, Chung S, Shneker B, Tatum Iv W, et al.
Epilepsia
. 2008 Nov;
50(3):434-42.
PMID: 19016830
Purpose: To assess anger/hostility during treatment with lamotrigine adjunctive therapy versus levetiracetam adjunctive therapy in patients with partial seizures. Methods: This randomized, double-blind, parallel-group study in adults with partial seizures...
7.
Fakhoury T, Miller J, Hammer A, Vuong A
Drugs Aging
. 2008 Oct;
25(11):955-62.
PMID: 18947263
Background: Both epilepsy and depressive symptoms are more prevalent in older individuals than in any other age group. Furthermore, depressive symptoms are among the most common interictal psychiatric co-morbid disorders...
8.
Holmes G, Frank L, Sheth R, Philbrook B, Wooten J, Vuong A, et al.
Epilepsy Res
. 2008 Sep;
82(2-3):124-32.
PMID: 18778916
Purpose: To evaluate the efficacy, tolerability, and effects on behavior and psychosocial functioning of lamotrigine monotherapy in children with newly diagnosed typical absence seizures. Patients And Methods: Children meeting enrollment...
9.
Miller J, Kustra R, Vuong A, Hammer A, Messenheimer J
Drugs
. 2008 Jul;
68(11):1493-509.
PMID: 18627207
Occurring in up to 80% of patients with epilepsy, depression in epilepsy may manifest as (i) major depressive disorder, meeting Diagnostic and Statistical Manual, 4th edition (DSM-IV) diagnostic criteria; (ii)...
10.
Tompson D, Ali I, Oliver-Willwong R, Job S, Zhu L, Lemme F, et al.
Epilepsia
. 2007 Sep;
49(3):410-7.
PMID: 17825077
Purpose: To compare the pharmacokinetics (PK) of lamotrigine (LTG) when converting from twice-daily immediate-release (LTG-IR) to once-daily extended-release (LTG-XR) in subjects with epilepsy. Methods: An open-label, conversion study was conducted,...